Home
Conditions
Pancreatic Cancer

Clinical trial condition

Pancreatic Cancer

Explore clinical trials studying Pancreatic Cancer. Study availability and eligibility vary by location and protocol.

1,289 public trials 284 recruiting studies

Refine in advanced search Browse all conditions

Pancreatic Cancer trial results

Completed

Nasobiliary Drain Assisted EUS-guided Gastroenterostomies in Unresectable Malignant Gastric Outlet Obstruction

NCT04660695

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +12 more
Locations: Christian Medical College Vellore, India

Clinica Universidad de Navarra Pamplona, Navarre, Spain

Complejo Hospitalario de Navarra Pamplona, Navarre, Spain

Hospital General Universitario de Alicante Alicante, Spain

View Trial Details

Completed

A Dose Escalation Safety Study of Locally-Delivered Gemcitabine in Pancreatic Cancer

NCT02237157

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations: El Camino Hospital, Oncology Mountain View, California, United States

Florida Hospital Tampa, Florida, United States

View Trial Details

Completed

AZD5153 in Patients With Relapsed or Refractory Solid Tumors, Including Lymphomas

NCT03205176

Conditions: Adnexal Diseases, Breast Cancer, Breast Diseases, +38 more
Locations: Research Site Sarasota, Florida, United States

Research Site Oklahoma City, Oklahoma, United States

Research Site Nashville, Tennessee, United States

Research Site Toronto, CA, Canada

View Trial Details

Completed

Immune Checkpoint Inhibition (Tremelimumab and/or MEDI4736) in Combination With Radiation Therapy in Patients With Unresectable Pancreatic Cancer

NCT02311361

Conditions: Cancer of Pancreas, Cancer of the Pancreas, Digestive System Diseases, +9 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

BYL719 in Combination With Gemcitabine and (Nab)-Paclitaxel in Locally Advanced and Metastatic Pancreatic Cancer

NCT02155088

Conditions: Digestive System Diseases, Digestive System Neoplasms, Disease Attributes, +12 more
Locations: H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States

View Trial Details

Completed

Open-label Study of CS-1008 for Subjects With Untreated and Unresectable Pancreatic Cancer

NCT00521404

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations: Birmingham, Alabama, United States

Washington D.C., District of Columbia, United States

Fort Myers, Florida, United States

Atlanta, Georgia, United States

View Trial Details

Completed

Effect of Multi-Media Tool on Enrollment in Oncology Clinical Trials

NCT02020252

Conditions: Behavior, Communication, Digestive System Diseases, +19 more
Locations: University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States

View Trial Details

Completed

Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer

NCT00112658

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations: Centre Hospitalier Universitaire d'Amiens Amiens, France

Hopital Duffaut Avignon, France

Centre Hospitalier General Belfort, France

Centre Hospitalier Regional de Besancon - Hopital Jean Minjoz Besançon, France

View all 55 locations

View Trial Details

Completed

Gemcitabine and Pulse Dose Erlotinib in Second Line Treatment of Advanced Pancreatic Cancer

NCT02154737

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations: UCSD Moores Cancer Center La Jolla, California, United States

View Trial Details

Completed

Genistein, Gemcitabine, and Erlotinib in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

NCT00376948

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations: Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States

M. D. Anderson Cancer Center at University of Texas Houston, Texas, United States

View Trial Details

Pancreatic Cancer

Pancreatic Cancer trial results

Related conditions